Yaacov-Garbeli Dana has filed 7 insider transactions across 1 company since April 2023.
Most recent transaction: a grant/award of 26316 shares of Entera Bio Ltd. ($ENTX) on July 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 26316 | $0.00 | 113,047.0000 | 37,650,179 | 30.34% | 0.07% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 37,650,179 | 9999.99% | 0.35% |
| April 19, 2024 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 30151 | $0.00 | 86,731.0000 | 29,007,794 | 53.29% | 0.10% |
| April 19, 2024 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 29,007,794 | 9999.99% | 0.45% |
| April 19, 2024 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 29,007,794 | 9999.99% | 0.45% |
| April 19, 2024 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 30151 | $0.00 | 86,731.0000 | 29,007,794 | 53.29% | 0.10% |
| April 24, 2023 | Entera Bio Ltd. | $ENTX | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |